B12 forms: tablets, under-the-tongue use and injections

How B12 forms and routes are compared and what a study in older adults found.

Key points

  • Cyanocobalamin and methylcobalamin are used in B12 supplements; there is no evidence that one form has an absorption advantage. When choosing, check the form and amount of vitamin per serving. [1] [2] [3] [4] [5] See the evidence 1
  • Sublingual tablets have shown no overall advantage over swallowing. Convenience may guide the choice; if absorption is impaired or symptoms are pronounced, discuss B12 replacement with a doctor. [1] [2] [3] [4] [5] See the evidence 1
  • Among people aged 65 and over with low B12, the studied oral and injection regimens achieved the target blood vitamin level about equally often at eight weeks. At one year, it was no longer possible to show that the oral regimen was no worse than injections. [3] See the evidence 1

Practical guide

Check the conclusions and whether they apply to your situation.

Vitamin B12 is available in different forms and routes. The choice depends on the goal and the reasons for low vitamin levels.

Key points

Why these conclusions

Forms and routes

Cyanocobalamin and methylcobalamin have been studied as B12 forms; the admitted review found no evidence that either has an absorption advantage. Sublingual tablets showed no overall advantage over swallowing. [1] [2] [3] [4] [5]

In people aged 65 and over with low B12, oral and intramuscular cyanocobalamin were compared. At eight weeks, 133 of 140 taking it orally and 129 of 143 receiving injections reached the target B12 level; at one year, the figures were 103 of 140 and 115 of 143 respectively. The prespecified criterion of being no worse than injections was met at eight weeks, but not at one year; confidence is low, 2 out of 4. [3]

The oral regimen studied was 1 mg daily for the first eight weeks, then 1 mg once weekly; the injection regimen was different. This describes one trial, not a universal prescription. [3]

By week 8, B12 reached ≥211 pg/mL in 133 of 140 participants taking it orally and 129 of 143 receiving injections. At one year, the figures were 103 of 140 (73.6%) and 115 of 143 (80.4%). Initially, oral use met the prespecified criterion of being no worse than injections; at one year it did not.

ParameterData
ResultBy week 8, B12 reached ≥211 pg/mL in 133 of 140 participants taking it orally and 129 of 143 receiving injections. At one year, the figures were 103 of 140 (73.6%) and 115 of 143 (80.4%). Initially, oral use met the prespecified criterion of being no worse than injections; at one year it did not.
Participants283 people aged 65 and over with B12 <211 pg/mL: 140 received oral B12 and 143 injections; 229 completed one year
FormCyanocobalamin Optovite: solution from ampoules taken orally
DoseOral: 1 mg daily for the first 8 weeks, then 1 mg once weekly
Dose basisOral: 1 mg daily for the first 8 weeks, then 1 mg once weekly
ComparatorThe same cyanocobalamin intramuscularly: 1 mg every other day in weeks 1–2, once weekly in weeks 3–8, once monthly in weeks 9–52
Duration52 weeks
Confidence2/4: One open-label study: participants knew the route. Of 283 participants, 229 completed one year of follow-up. For the difference in proportions at one year, the 95% confidence interval was −16.6 to +2.9 percentage points. Specific regimens were compared, including infrequent oral use after week eight.
Evidence base1 study
Sources[3]

Information from the source

NameDescriptionSources
Cyanocobalamin and methylcobalaminBoth forms of B12 were used in studies. There is no evidence that one has an absorption advantage. The amount of B12 per dose and the route matter on the label.[1]
Swallowing or dissolving under the tongueSublingual tablets showed no overall advantage over oral ingestion. A study in vegans and vegetarians compared two doses of sublingual cyanocobalamin, not two routes.[1] [2]
Comparison with injectionsIn a study of people aged 65 and over, cyanocobalamin solution was taken orally every day for eight weeks, then weekly. After one year this regimen could no longer confidently be considered comparable to injections. If absorption is impaired or symptoms are pronounced, choose the B12 replacement route with a doctor.[3] [1]
B12 without a specified formThe fatigue study described oral B12, while the borderline B12 study used tablets. The chemical form was not specified in the available descriptions of these studies.[4] [5]

More details

Choosing a replacement route

If absorption is impaired or symptoms are pronounced, choose the B12 replacement route with a doctor. The study in vegans and vegetarians compared two doses of a sublingual product, not sublingual use with swallowing. [1] [2] [3] [4] [5]

Sources

  1. Vitamin B12 — Health Professional Fact Sheet (NIH ODS). https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/
  2. Effect of two different sublingual dosages of vitamin B(12) on cobalamin nutritional status in vegans and vegetarians with a marginal deficiency: A randomized controlled trial. https://pubmed.ncbi.nlm.nih.gov/29499976/
  3. Oral versus intramuscular administration of vitamin B12 for vitamin B12 deficiency in primary care: a pragmatic, randomised, non-inferiority clinical trial (OB12). https://doi.org/10.1136/bmjopen-2019-033687
  4. Surplus vitamin B12 use does not reduce fatigue in patients with Irritable Bowel Syndrome or inflammatory bowel disease: A randomized double-blind placebo-controlled trial. https://pubmed.ncbi.nlm.nih.gov/29460813/
  5. Oral vitamin B12 for patients suspected of subtle cobalamin deficiency: a multicentre pragmatic randomised controlled trial. https://doi.org/10.1186/1471-2296-12-2

Methodology: Subpages evidence-led supplement pipeline v1

Ingredient overview: Vitamin B12